What does neuromodulation division — operating expenses mean?

This metric represents the total costs incurred by the Neuromodulation Division to support its day-to-day business activities, excluding non-operating items. It encompasses all functional expenditures required to maintain and advance the division's neuromodulation product portfolio. Monitoring this helps investors assess the cost structure and operational efficiency of this specific business unit.

Vivani Medical VANI Neuromodulation Division — Operating Expenses

Other segment segments

Biopharm Division

$6M0.0%

Neurostimulation Division

$2.6M—

Similar metrics at other companies

LIVNNeuromodulation — Operating Income

$44.15M-15.7%

LIVNNeuromodulation — Selling, general, and administrative

$52.62M+10.6%

LIVNNeuromodulation — Cost of Sales

$14.22M+6.2%

LIVNNeuromodulation — Net revenue

$151.79M+9.3%

LIVNNeuromodulation — R&D

$40.79M+59.5%

LIVNNeuromodulation — CapEx

$8.84M+335%

Other financials

Income statement

See full

Revenue-—

Gross profit$130.0K—

Operating income-$6.8M-4.0%

Net income-$6.8M-7.6%

EPS (diluted)-$0.08+27.3%

Balance sheet

See full

Cash & equivalents$19.0M+57.7%

Total debt$18.3M-3.5%

Total equity$19.1M+64.2%

Total assets$42.4M+19.5%

Cash flow

See full

Operating cash flow-$6.2M-20.0%

CapEx$3.0K-40.0%

Free cash flow-$6.2M-19.9%

Valuation

See full

Market cap$106.93M+40.0%

Enterprise value$106.17M+19.3%

Profitability

See full

Gross margin36.3%—

Operating margin-1,004.9%—

Net margin-994.1%—

FCF margin-832.3%—

Returns & leverage

See full

Return on equity-176.4%+175pp

Debt / equity1×-0.7×

Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's neuromodulation division — operating expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vivani Medical's neuromodulation division — operating expenses?: Vivani Medical (VANI) reported neuromodulation division — operating expenses of $800K in Q1 2026.
What does neuromodulation division — operating expenses mean?: This metric represents the total costs incurred by the Neuromodulation Division to support its day-to-day business activities, excluding non-operating items. It encompasses all functional expenditures required to maintain and advance the division's neuromodulation product portfolio. Monitoring this helps investors assess the cost structure and operational efficiency of this specific business unit.